SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-23-002110
Filing Date
2023-01-09
Accepted
2023-01-09 09:22:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm232543d1_defa14a.htm DEFA14A 13256
  Complete submission text file 0001104659-23-002110.txt   14440
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
First Wave BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 464993860 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37853 | Film No.: 23516876
SIC: 2834 Pharmaceutical Preparations